.png)
In the current landscape of laboratory services, analytical excellence, turnaround time for result release, and cost effectiveness per test are increasingly becoming similar across institutions.
As these technical attributes converge, the perceived value of the service is no longer determined solely by analytical performance, but rather by how the generated information is organized, delivered, and integrated into the clinical journey.
This reality can be observed when comparing two laboratories that perform the same test with equivalent analytical quality, turnaround time, and cost per analysis. Laboratory A limits its delivery to a printed report and the transmission of a PDF file via messaging applications to the patient and the requesting physician.
Laboratory B, in contrast, provides results through a digital platform offering harmonized data, longitudinal visualization, risk alerts, and integration with the electronic health record.
Although both produce technically comparable results, the difference lies in the intelligence applied to the use of information and in the ability to support clinical decision making in a continuous and contextualized manner.
This example illustrates a broader phenomenon within the sector: the transformation of laboratory testing into a commodity. As with basic products, pricing becomes primarily determined by supply and demand dynamics, generating deflationary pressure and weakening customer loyalty.
In this context, clients tend to choose laboratories primarily based on cost and secondarily on geographic convenience. This trend is intensified by the structure of the Brazilian market, which registered 23,538 clinical laboratories in 2022, highlighting a highly competitive sector in which different providers offer services with very similar analytical quality, turnaround times, and costs.
As commoditization consolidates, it becomes insufficient for laboratories to restrict their value proposition to the simple delivery of test reports.
To prevent laboratory diagnostics from being reduced to an undifferentiated product, it is necessary to incorporate strategies that add real, measurable, and perceived clinical value throughout the continuum of care. It is at this point that data harmonization assumes a central role, by ensuring clinically validated clinical equivalence and semantic standardization among results originating from different laboratories, methods, and instruments.
This standardization not only reduces interpretative ambiguity, but also strengthens continuity of care and confidence in medical decision making.²
From a competitive strategy perspective, this approach aligns directly with Porter’s theory, according to which differentiation occurs when an organization offers a unique and relevant service to its audience.
By integrating results into the electronic health record and incorporating risk alerts based on harmonized data, the laboratory shifts its competitive position away from price competition toward a value proposition grounded in added value to the clinical journey.³
In such an environment, collaboration among healthcare professionals is naturally enhanced, as data become comparable, reliable, and longitudinally accessible.
Established experiences in pharmaceutical laboratories reinforce this logic. The democratization of data through orchestration layers and shared dashboards has enabled the optimization of experimental projects, ensured regulatory compliance, and accelerated batch release, with direct impacts on safety and on the speed of product development.
These cases demonstrate how technology applied to data organization and use is capable of resolving complex operational bottlenecks and generating sustainable gains.
By following the same principle, clinical laboratories that invest in process digitalization and data harmonization expand operational efficiency, reduce errors, improve cost predictability, and enhance the quality of information delivered throughout the care process.
In this digital transformation journey, technologies capable of ensuring data reliability, traceability, and homogeneity cease to be differentiators and become strategic requirements.
Within this context, OpenHealth Technologies stands out by addressing the most complex challenge: unifying laboratory data into a standardized, traceable, and clinically meaningful timeline, providing clear and integrated visualization for patients and for the entire healthcare ecosystem.
Learn how your institution can expand its competitive advantage through laboratory data harmonization.